Medical Care

Global Antisense Therapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Antisense Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Therapy.
The Antisense Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals, Inc.
Arbutus Biopharma (Tekmira)
Isarna Therapeutics
Arrowhead
Dicerna Pharmaceuticals
Quark Pharmaceuticals
Benitec Biopharma
Sylentis
Gradalis
Sarepta Therapeutics
Biogen
Segment by Type
RNA Antisense Therapy
DNA Antisense Therapy
Segment by Application
Cancer
Cardiovascular
HBV
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RNA Antisense Therapy
1.2.3 DNA Antisense Therapy
1.3 Market by Application
1.3.1 Global Antisense Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Therapy Market Perspective (2020-2031)
2.2 Global Antisense Therapy Growth Trends by Region
2.2.1 Global Antisense Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antisense Therapy Historic Market Size by Region (2020-2025)
2.2.3 Antisense Therapy Forecasted Market Size by Region (2026-2031)
2.3 Antisense Therapy Market Dynamics
2.3.1 Antisense Therapy Industry Trends
2.3.2 Antisense Therapy Market Drivers
2.3.3 Antisense Therapy Market Challenges
2.3.4 Antisense Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Therapy Players by Revenue
3.1.1 Global Top Antisense Therapy Players by Revenue (2020-2025)
3.1.2 Global Antisense Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antisense Therapy Revenue
3.4 Global Antisense Therapy Market Concentration Ratio
3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2024
3.5 Global Key Players of Antisense Therapy Head office and Area Served
3.6 Global Key Players of Antisense Therapy, Product and Application
3.7 Global Key Players of Antisense Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Therapy Breakdown Data by Type
4.1 Global Antisense Therapy Historic Market Size by Type (2020-2025)
4.2 Global Antisense Therapy Forecasted Market Size by Type (2026-2031)
5 Antisense Therapy Breakdown Data by Application
5.1 Global Antisense Therapy Historic Market Size by Application (2020-2025)
5.2 Global Antisense Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antisense Therapy Market Size (2020-2031)
6.2 North America Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antisense Therapy Market Size by Country (2020-2025)
6.4 North America Antisense Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Therapy Market Size (2020-2031)
7.2 Europe Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antisense Therapy Market Size by Country (2020-2025)
7.4 Europe Antisense Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Therapy Market Size (2020-2031)
8.2 Asia-Pacific Antisense Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antisense Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Antisense Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Therapy Market Size (2020-2031)
9.2 Latin America Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antisense Therapy Market Size by Country (2020-2025)
9.4 Latin America Antisense Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Therapy Market Size (2020-2031)
10.2 Middle East & Africa Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antisense Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Antisense Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Details
11.2.2 Ionis Pharmaceuticals, Inc. Business Overview
11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2020-2025)
11.2.5 Ionis Pharmaceuticals, Inc. Recent Development
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Arbutus Biopharma (Tekmira) Company Details
11.3.2 Arbutus Biopharma (Tekmira) Business Overview
11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2020-2025)
11.3.5 Arbutus Biopharma (Tekmira) Recent Development
11.4 Isarna Therapeutics
11.4.1 Isarna Therapeutics Company Details
11.4.2 Isarna Therapeutics Business Overview
11.4.3 Isarna Therapeutics Antisense Therapy Introduction
11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2020-2025)
11.4.5 Isarna Therapeutics Recent Development
11.5 Arrowhead
11.5.1 Arrowhead Company Details
11.5.2 Arrowhead Business Overview
11.5.3 Arrowhead Antisense Therapy Introduction
11.5.4 Arrowhead Revenue in Antisense Therapy Business (2020-2025)
11.5.5 Arrowhead Recent Development
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Details
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)
11.6.5 Dicerna Pharmaceuticals Recent Development
11.7 Quark Pharmaceuticals
11.7.1 Quark Pharmaceuticals Company Details
11.7.2 Quark Pharmaceuticals Business Overview
11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)
11.7.5 Quark Pharmaceuticals Recent Development
11.8 Benitec Biopharma
11.8.1 Benitec Biopharma Company Details
11.8.2 Benitec Biopharma Business Overview
11.8.3 Benitec Biopharma Antisense Therapy Introduction
11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2020-2025)
11.8.5 Benitec Biopharma Recent Development
11.9 Sylentis
11.9.1 Sylentis Company Details
11.9.2 Sylentis Business Overview
11.9.3 Sylentis Antisense Therapy Introduction
11.9.4 Sylentis Revenue in Antisense Therapy Business (2020-2025)
11.9.5 Sylentis Recent Development
11.10 Gradalis
11.10.1 Gradalis Company Details
11.10.2 Gradalis Business Overview
11.10.3 Gradalis Antisense Therapy Introduction
11.10.4 Gradalis Revenue in Antisense Therapy Business (2020-2025)
11.10.5 Gradalis Recent Development
11.11 Sarepta Therapeutics
11.11.1 Sarepta Therapeutics Company Details
11.11.2 Sarepta Therapeutics Business Overview
11.11.3 Sarepta Therapeutics Antisense Therapy Introduction
11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2020-2025)
11.11.5 Sarepta Therapeutics Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Antisense Therapy Introduction
11.12.4 Biogen Revenue in Antisense Therapy Business (2020-2025)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of RNA Antisense Therapy
Table 3. Key Players of DNA Antisense Therapy
Table 4. Global Antisense Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antisense Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antisense Therapy Market Share by Region (2020-2025)
Table 8. Global Antisense Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antisense Therapy Market Share by Region (2026-2031)
Table 10. Antisense Therapy Market Trends
Table 11. Antisense Therapy Market Drivers
Table 12. Antisense Therapy Market Challenges
Table 13. Antisense Therapy Market Restraints
Table 14. Global Antisense Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antisense Therapy Market Share by Players (2020-2025)
Table 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2024)
Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antisense Therapy, Headquarters and Area Served
Table 20. Global Key Players of Antisense Therapy, Product and Application
Table 21. Global Key Players of Antisense Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antisense Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Antisense Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antisense Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Antisense Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antisense Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Antisense Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antisense Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antisense Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antisense Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antisense Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Alnylam Pharmaceuticals Company Details
Table 47. Alnylam Pharmaceuticals Business Overview
Table 48. Alnylam Pharmaceuticals Antisense Therapy Product
Table 49. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Recent Development
Table 51. Ionis Pharmaceuticals, Inc. Company Details
Table 52. Ionis Pharmaceuticals, Inc. Business Overview
Table 53. Ionis Pharmaceuticals, Inc. Antisense Therapy Product
Table 54. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 55. Ionis Pharmaceuticals, Inc. Recent Development
Table 56. Arbutus Biopharma (Tekmira) Company Details
Table 57. Arbutus Biopharma (Tekmira) Business Overview
Table 58. Arbutus Biopharma (Tekmira) Antisense Therapy Product
Table 59. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 60. Arbutus Biopharma (Tekmira) Recent Development
Table 61. Isarna Therapeutics Company Details
Table 62. Isarna Therapeutics Business Overview
Table 63. Isarna Therapeutics Antisense Therapy Product
Table 64. Isarna Therapeutics Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 65. Isarna Therapeutics Recent Development
Table 66. Arrowhead Company Details
Table 67. Arrowhead Business Overview
Table 68. Arrowhead Antisense Therapy Product
Table 69. Arrowhead Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 70. Arrowhead Recent Development
Table 71. Dicerna Pharmaceuticals Company Details
Table 72. Dicerna Pharmaceuticals Business Overview
Table 73. Dicerna Pharmaceuticals Antisense Therapy Product
Table 74. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 75. Dicerna Pharmaceuticals Recent Development
Table 76. Quark Pharmaceuticals Company Details
Table 77. Quark Pharmaceuticals Business Overview
Table 78. Quark Pharmaceuticals Antisense Therapy Product
Table 79. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 80. Quark Pharmaceuticals Recent Development
Table 81. Benitec Biopharma Company Details
Table 82. Benitec Biopharma Business Overview
Table 83. Benitec Biopharma Antisense Therapy Product
Table 84. Benitec Biopharma Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 85. Benitec Biopharma Recent Development
Table 86. Sylentis Company Details
Table 87. Sylentis Business Overview
Table 88. Sylentis Antisense Therapy Product
Table 89. Sylentis Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 90. Sylentis Recent Development
Table 91. Gradalis Company Details
Table 92. Gradalis Business Overview
Table 93. Gradalis Antisense Therapy Product
Table 94. Gradalis Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 95. Gradalis Recent Development
Table 96. Sarepta Therapeutics Company Details
Table 97. Sarepta Therapeutics Business Overview
Table 98. Sarepta Therapeutics Antisense Therapy Product
Table 99. Sarepta Therapeutics Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 100. Sarepta Therapeutics Recent Development
Table 101. Biogen Company Details
Table 102. Biogen Business Overview
Table 103. Biogen Antisense Therapy Product
Table 104. Biogen Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)
Table 105. Biogen Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report


List of Figures
Figure 1. Antisense Therapy Picture
Figure 2. Global Antisense Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antisense Therapy Market Share by Type: 2024 VS 2031
Figure 4. RNA Antisense Therapy Features
Figure 5. DNA Antisense Therapy Features
Figure 6. Global Antisense Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antisense Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. HBV Case Studies
Figure 11. Other Case Studies
Figure 12. Antisense Therapy Report Years Considered
Figure 13. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antisense Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antisense Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Antisense Therapy Market Share by Players in 2024
Figure 17. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2024
Figure 19. North America Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antisense Therapy Market Share by Country (2020-2031)
Figure 21. United States Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antisense Therapy Market Share by Country (2020-2031)
Figure 25. Germany Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antisense Therapy Market Share by Region (2020-2031)
Figure 33. China Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antisense Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antisense Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 49. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 50. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 51. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 52. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 53. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 54. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 55. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 56. Sylentis Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 57. Gradalis Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 58. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 59. Biogen Revenue Growth Rate in Antisense Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies